Spiracur announced US Food and Drug Administration (FDA) clearance and European CE Mark approval of the SNaP Plus Wound Care Cartridge, a mechanically powered, single use Negative Pressure Wound Therapy (NPWT) solution for healing chronic and acute wounds.

The company began shipping SNaP Plus Systems to customers on December 23, 2014.

Spiracur, developer of the SNaP (Smart Negative Pressure) System, has provided an increasing number of clinicians with the only mechanically powered system within advanced wound care.

The company’s expanding family of lightweight, disposable SNaP Systems has been delivering clinically proven NPWT to patients who suffer from chronic or acute wounds for over four years.

The new SNaP Plus delivers all of the proven clinical advantages of the SNaP Wound Care System technology platform including reduced dressing application time; off-the-shelf availability for wound management efficiency; single-use for reduced risk of hospital acquired infections and cross contamination; and a documented improvement in patient satisfaction when NPWT is delivered through a SNaP system.

The SNaP Plus is equipped with a larger cartridge capacity, at two-and-a-half times larger than the original SNaP cartridge, in order to meet hospitals’ needs to manage higher volumes of wound exudate.

"We are successfully addressing the top wound care priorities for hospitals and long term care facilities with our SNaP Plus by helping to reduce budgets and control costs; decrease the chances of hospital-acquired infections; improve upon wound management efficiency; and increase the patient’s comfort and mobility," said Chris Fashek, president and chief executive officer for Spiracur.

Spiracur’s SNaP Plus offers proven healing combined with improved safety and ease-of-use, which is critical for hospitals and long term care facilities. Typical application times are less than 10 minutes, and the off-the-shelf availability eliminates rental paperwork or the burdensome procurement process.